C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations

New England Journal of Medicine Jul 17, 2019

Butler CC, et al. - Via a multicenter, open-label, randomized, controlled trial with patients who have chronic obstructive pulmonary disease (COPD), researchers examined the value of point-of-care testing of C-reactive protein (CRP) for lowering unnecessary antibiotic use without harming patients who have acute exacerbations of COPD. They randomized a total of 653 patients who consulted a clinician at 1 of 86 general medical practices in England and Wales for an acute exacerbation of COPD to either usual care guided by CRP point-of-care testing (CRP-guided group) or usual care alone (usual-care group). Observations revealed a lower percentage of patients who reported antibiotic use and who received antibiotic prescriptions from clinicians in primary care clinics in correlation to CRP-guided prescribing of antibiotics for exacerbations of COPD, with no evidence of harm.

Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen